Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ · Healthcare
Acadia Pharmaceuticals Inc. Shareholder Equity 2009–2025
Acadia Pharmaceuticals Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Acadia Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 1.23B, a 67.49% increase year-over-year.
- Acadia Pharmaceuticals Inc. shareholder equity for 2025 were 1.23B, a 67.49% increase from 2024.
- Acadia Pharmaceuticals Inc. shareholder equity for 2024 were 732.8M, a 69.72% increase from 2023.
- Acadia Pharmaceuticals Inc. shareholder equity for 2023 were 431.8M, a 7.83% increase from 2022.
- Acadia Pharmaceuticals Inc. shareholder equity for 2022 were 400.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Acadia Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,227 |
| 2024 | $733 |
| 2023 | $432 |
| 2022 | $400 |
| 2021 | $541 |
| 2020 | $627 |
| 2019 | $699 |
| 2018 | $479 |
| 2017 | $335 |
| 2016 | $518 |
| 2015 | $200 |
| 2014 | $309 |
| 2013 | $182 |
| 2012 | $85 |
| 2011 | $23 |
Acadia Pharmaceuticals Inc. Shareholder Equity — FAQ
Acadia Pharmaceuticals Inc. (ACAD) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACAD's shareholder equity history?
The chart and table above show Acadia Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.